ADARB1 and acute myeloid leukemia: ADAR2, in contrast, predominantly acts as a tumor suppressor, particularly in neural-origin tumors (GBM) and specific epithelial cancers (HCC, GC, AML), by restoring transcriptomic fidelity and editing tumor suppressor pathways.